Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Bullboard - Stock Discussion Forum Oncology Pharma Inc (EM) ONPH

Healthcare Biotechnology
Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019. Oncology Pharma Inc. was... see more

Bullboard (EXPM:ONPH)

View:
User Avatar Image
(0)
•••
  • OldbaldyX
Comment by Oldbaldyon Oct 22, 2023 8:47am

RE:ValiRx and TheoremRx - VAL201 - US$61M plus royalties

So is there any truth in this....?
82
User Avatar Image
(2)
•••
  • Carolpeters24X
Post by Carolpeters24on Jul 26, 2022 10:31am

ValiRx and TheoremRx - VAL201 - US$61M plus royalties

Dr Ken Sorensen, Chairman of TheoremRx We are delighted out latest fundraising od $250m has brought in multiple financial institutions as we now move forward with our strategic plans. Dr Ken Sorensen, ...more  
924